Here's Why Mirati Therapeutics Is Surging Today

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 16, 2019 at 7:02 PM.

  1. #1 cafead, May 16, 2019 at 7:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Shares of Mirati Therapeutics (NASDAQ: MRTX), a clinical-stage biotechnology company developing new cancer drugs, are on the move thanks to enthusiasm for its experimental KRAS inhibitor.

    article source
     
    Quote

  2. #2 VINU ANALYST, Dec 31, 2019 at 7:45 AM
    VINU ANALYST

    VINU ANALYST Guest

    Are they still recruiting for the cliical trial?
     
    Quote
  3. #3 VINU ANALYST, Jan 7, 2020 at 1:34 AM
    VINU ANALYST

    VINU ANALYST Guest

    Some clinical locations are struggling to get the MRTX849 for the trials & have difficulties to continue the trial. Is this a rumour?
     
    Quote
Reply to Thread